HealthStream, Inc.
NASDAQ:HSTM · NASDAQ Global Select
-$0.34 today
Vol 0.30M · Avg 0.25M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:HSTM · Revenue to Net Income
Key Ratios
Analysis
$311.8M of revenue converted into $19.9M of net income for the selected period. Gross margin is 64.9% and net margin is 6.4%, showing how much revenue survives after costs and taxes. EPS is $0.67, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $304.1M +4.3% | $291.6M +4.5% | $279.1M +4.6% | $266.8M +3.9% | $256.7M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $107.2M +9.5% | $97.9M +3.1% | $95.0M +4.3% | $91.1M +0.1% | $91.0M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $196.9M +1.6% | $193.7M +5.3% | $184.0M +4.8% | $175.7M +6.0% | $165.7M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 64.7% -1.7pp | 66.4% +0.5pp | 65.9% +0.1pp | 65.8% +1.3pp | 64.5% | 9.8% | 28.9% | 38.3% |
| Research & Development | $51.0M +4.3% | $48.9M +7.4% | $45.5M +2.9% | $44.3M +6.3% | $41.7M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $82.2M -0.2% | $82.3M +1.1% | $81.4M +0.5% | $81.0M +2.3% | $79.2M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $176.6M +2.4% | $172.4M +2.6% | $168.0M +2.9% | $163.2M +3.6% | $157.6M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $43.5M +5.4% | $41.2M +0.4% | $41.1M +8.3% | $37.9M +3.1% | $36.8M | $374.2M | $1.2B | $631.8M |
| EBITDA | $66.7M +1.0% | $66.0M +10.8% | $59.6M +11.3% | $53.5M +20.1% | $44.6M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 21.9% -0.7pp | 22.6% +1.3pp | 21.4% +1.3pp | 20.1% +2.7pp | 17.4% | 5.6% | 46.3% | 42.0% |
| Operating Income | $20.2M -4.9% | $21.3M +32.9% | $16.0M +28.7% | $12.4M +54.5% | $8.1M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 6.7% -0.6pp | 7.3% +1.6pp | 5.7% +1.1pp | 4.7% +1.5pp | 3.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $3.3M -12.9% | $3.8M +62.7% | $2.4M +430.6% | $444.0K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $3.0M -15.2% | $3.5M +41.1% | $2.5M -20.5% | $3.1M +1185.1% | -$289.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $23.2M -6.4% | $24.8M +34.0% | $18.5M +18.8% | $15.6M +100.7% | $7.8M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 7.6% -0.9pp | 8.5% +1.9pp | 6.6% +0.8pp | 5.8% +2.8pp | 3.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $4.9M +1.7% | $4.8M +45.4% | $3.3M -5.6% | $3.5M +81.9% | $1.9M | $1.3B | -$1.6B | $745.2M |
| Net Income | $18.3M -8.3% | $20.0M +31.5% | $15.2M +25.8% | $12.1M +106.9% | $5.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | 6.0% -0.8pp | 6.9% +1.4pp | 5.5% +0.9pp | 4.5% +2.3pp | 2.3% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $1 -7.6% | $1 +32.0% | $1 +28.2% | $0 +105.3% | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $1 -7.6% | $1 +32.0% | $1 +28.2% | $0 +116.7% | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $30.0M -1.2% | $30.4M -0.6% | $30.6M -0.3% | $30.6M -2.8% | $31.5M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $30.1M -1.3% | $30.5M -0.4% | $30.7M -0.1% | $30.7M -2.8% | $31.6M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B

Butterfly Network, Inc.
NYSE:BFLY
$1.89B

CareDx, Inc
NASDAQ:CDNA
$1.26B

AMN Healthcare Services, Inc.
NYSE:AMN
$1.20B

Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
$1.19B

Nutex Health, Inc.
NASDAQ:NUTX
$889.81M

Theravance Biopharma, Inc.
NASDAQ:TBPH
$856.81M

Replimune Group, Inc.
NASDAQ:REPL
$840.64M

Evolent Health, Inc.
NYSE:EVH
$501.67M

Myriad Genetics, Inc.
NASDAQ:MYGN
$422.18M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does HSTM generate?
HealthStream, Inc. (HSTM) reported $304.06M of revenue in fiscal 2025.
Is HSTM profitable?
HealthStream, Inc. (HSTM) reported $18.34M of net income, with a net margin of 6.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.